Chapters

Transcript

Video

ESMO26: Vincent Xu, MD on KIM1 in Kidney Cancer

Vincent (Wenxin) Xu, MD , shows among patients with advanced kidney cancer on immunotherapy alone, KIM-1 reductions were seen in immune-inflamed tumors, while no KIM-1 drop was linked to immune-depleted tumors.

Published

November 3, 2026

Created by

Dana-Farber

Related Presenters

Wenxin Xu, MD

Wenxin Xu, MD

Medical Oncology

View full Profile